Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
7.75M
-
Shares change
-
+7.75M
-
Total reported value, excl. options
-
$26.7M
-
Value change
-
+$26.7M
-
Number of buys
-
14
-
Price
-
$3.44
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2020
14 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q3 2020.
Summit Therapeutics Inc. - COM (SMMT) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.75M shares
.
Largest 10 shareholders include Polar Capital LLP (5M shares), JPMORGAN CHASE & CO (1.57M shares), BAILLIE GIFFORD & CO (372K shares), RENAISSANCE TECHNOLOGIES LLC (303K shares), MORGAN STANLEY (210K shares), UBS Group AG (141K shares), MIRABELLA FINANCIAL SERVICES LLP (36.4K shares), WELLS FARGO & COMPANY/MN (35K shares), HSBC HOLDINGS PLC (27.3K shares), and GEODE CAPITAL MANAGEMENT, LLC (19.4K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.